REFERENCES
1. National Cancer Institute, NIH. Liver cancer causes, risk factors, and prevention. Available from https://www.cancer.gov/types/liver/what-is-liver-cancer/causes-risk-factors [Last accessed 15 Mar 2023].
3. Younossi ZM. Non-alcoholic fatty liver disease - a global public health perspective. J Hepatol 2019;70:531-44.
4. Estes C, Razavi H, Loomba R, Younossi Z, Sanyal AJ. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology 2018;67:123-33.
5. Wong LL, Hernandez B, Kwee S, Albright CL, Okimoto G, Tsai N. Healthcare disparities in Asians and Pacific Islanders with hepatocellular cancer. Am J Surg 2012;203:726-32.
6. Yang B, Liu JB, So SK, et al. Disparities in hepatocellular carcinoma incidence by race/ethnicity and geographic area in California: implications for prevention. Cancer 2018;124:3551-9.
7. Danos D, Leonardi C, Gilliland A, et al. Increased risk of hepatocellular carcinoma associated with neighborhood concentrated disadvantage. Front Oncol 2018;8:375.
8. Shebl FM, Capo-Ramos DE, Graubard BI, McGlynn KA, Altekruse SF. Socioeconomic status and hepatocellular carcinoma in the United States. Cancer Epidemiol Biomarkers Prev 2012;21:1330-5.
9. Stewart SL, Kwong SL, Bowlus CL, et al. Racial/ethnic disparities in hepatocellular carcinoma treatment and survival in California, 1988-2012. World J Gastroenterol 2016;22:8584-95.
10. Chang ET, Keegan TH, Gomez SL, et al. The burden of liver cancer in Asians and Pacific Islanders in the Greater San Francisco Bay Area, 1990 through 2004. Cancer 2007;109:2100-8.
11. McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology 2021;73 Suppl 1:4-13.
12. Harlan LC, Parsons HM, Wiggins CL, Stevens JL, Patt YZ. Treatment of hepatocellular carcinoma in the community: disparities in standard therapy. Liver Cancer 2015;4:70-83.
13. Mathur AK, Osborne NH, Lynch RJ, Ghaferi AA, Dimick JB, Sonnenday CJ. Racial/ethnic disparities in access to care and survival for patients with early-stage hepatocellular carcinoma. Arch Surg 2010;145:1158-63.
14. Howell J, Van Gemert C, Lemoine M, Thursz M, Hellard M. Overview of hepatitis B prevalence, prevention, and management in the Pacific Islands and Territories. J Gastroenterol Hepatol 2014;29:1854-66.
15. National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Care Services; Committee on Health Care Utilization and Adults with Disabilities. Factors that affect health-care utilization. In: Health-care utilization as a proxy in disability determination. Washington (DC): National Academies Press (US); 2018. p. 21-38.
16. U.S. Census Bureau. New census data show differences between urban and rural populations. Available from: https://content.govdelivery.com/accounts/USCENSUS/bulletins/1782904 [Last accessed on 14 Mar 2023].
17. U.S. Department of Health and Human Services, Office of Minority Health. Minority population profiles: Native Hawaiian/Other Pacific Islander. Available from: https://minorityhealth.hhs.gov/omh/browse.aspx?lvl=3&lvlid=65 [Last accessed on 14 Mar 2023].
18. Kaiser Family Foundation (KFF). Health care disparities among Asian, Native Hawaiian, and Other Pacific Islander (NHOPI) People. Available from: https://www.kff.org/racial-equity-and-health-policy/issue-brief/health-care-disparities-among-asian-native-hawaiian-and-other-pacific-islander-nhopi-people/ [Last accessed on 14 Mar 2023].
19. NIH. State cancer profiles: liver and bile duct, 2014-2018. Available from: www.statecancerprofiles.cancer.gov [Last accessed on 14 Mar 2023].
20. Heimbach JK, Kulik LM, Finn RS et al. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology 2018;67:358-80.
21. Roberts LR, Sirlin CB, Zaiem F, et al. Imaging for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Hepatology 2018;67:401-21.
22. U.S. Census Bureau. Population estimates, July 1, 2021 (V2021); quick facts. Available from https://www.supremecourt.gov/opinions/URLs_Cited/OT2021/19-1392/19-1392-7.pdf [Last accessed on 14 Mar 2023].
23. Xie Y. Hepatitis b virus-associated hepatocellular carcinoma. In: Cai Q, Yuan Z, Lan K. (eds) Infectious agents associated cancers: epidemiology and molecular biology. advances in experimental medicine and biology, vol 1018. Singapore: Springer; 2017. p. 11-21.
24. CDC. People born outside of the United States and viral hepatitis. Available from: https://www.cdc.gov/hepatitis/populations/Born-Outside-United-States.htm [Last accessed on 14 Mar 2023].
25. U.S. Department of Health and Human Services; National Institute of Diabetes and Digestive and Kidney Diseases. Hepatitis B. Available from: https://www.niddk.nih.gov/health-information/liver-disease/viral-hepatitis/hepatitis-b [Last accessed on 14 Mar 2023].
26. Lasitani S, Hattori C, Elisara T, Araneta MR. Assessing hepatitis B knowledge among Native Hawaiians and Pacific Islanders in San Diego. J Immigr Minor Health 2021;23:1193-7.
27. Abara WE, Collier MG, Teshale EH. Impact of universal infant hepatitis B vaccination in the US-affiliated Pacific Islands, 1985-2015. Vaccine 2017;35:997-1000.
28. Thursz M, Njie R, Lemoine M. Global eradication of hepatitis B-feasible or fallacy? Nat Rev Gastroenterol Hepato 2012;9:492-4.
29. Mast EE, Alter MJ, Margolis HS. Strategies to prevent and control hepatitis B and C virus infections: a global perspective. Vaccine 1999;17:1730-3.
30. Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J Hepatol 2010;53:348-56.
31. Wong RJ, Jain MK, Therapondos G, Niu B, Kshirsagar O, Thamer M. Antiviral therapy reduces risk of cirrhosis in noncirrhotic HBV patients among 4 urban safety-net health systems. Am J Gastroenterol 2021;116:1465-75.
32. Thursz M, Cooke GS, Hall AJ. Hepatitis B treatment in resource poor settings: time for action. Trop Med Int Health 2010;15:2-4.
33. Hanafiah K, Groeger J, Flaxman AD, Wiersma ST. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013;57:1333-42.
34. Howard J, Ali H. Injecting drug use among young people in Pacific Island countries and territories: a review of the evidence. Drug Alcohol Rev 2013;32:631-3.
35. Ali H, Howard J. Prevalence of injecting drug use among youth in the Pacific Island countries and territories: what is the evidence? Asia Pac J Public Health 2011;23:112-4.
36. Islanders pay heavy price for abandoning traditional diet. Bull World Health Organ 2010;88:484-5.
37. Pattison RJ, Esteban JP, Sempokuya T, et al. Nonalcoholic fatty liver disease: an important consideration for primary care providers in Hawai'i. Hawaii J Health Soc Welf 2020;79:180-6.
38. Setiawan VW, Stram DO, Porcel J, Lu SC, Le Marchand L, Noureddin M. Prevalence of chronic liver disease and cirrhosis by underlying cause in understudied ethnic groups: the multiethnic cohort. Hepatology 2016;64:1969-77.
39. Sliz E, Sebert S, Würtz P, et al. NAFLD risk alleles in PNPLA3, TM6SF2, GCKR and LYPLAL1 show divergent metabolic effects. Hum Mol Genet 2018;27:2214-23.
40. Lee J, Kim Y, Friso S, Choi SW. Epigenetics in non-alcoholic fatty liver disease. Mol Aspects Med 2017;54:78-88.
41. Rasanathan K, Tukuitonga CF. Tobacco smoking prevalence in Pacific Island countries and territories: a review. N Z Med J 2007;120:U2742.
42. Kessaram T, McKenzie J, Girin N, et al. Tobacco smoking in islands of the Pacific Region, 2001-2013. Prev Chronic Dis 2015;12:E212.
43. CDC. Asian, Native Hawaiian, and Pacific Islander people experience a health burden from commercial tobacco. Available from: https://www.cdc.gov/tobacco/health-equity/anhpi/health-burden.html [Last accessed on 14 Mar 2023].
44. Kessaram T, McKenzie J, Girin N, et al. Alcohol use in the Pacific region: results from the STEPwise approach to surveillance, Global School-Based Student Health Survey and Youth Risk Behavior Surveillance System. Drug Alcohol Rev 2016;35:412-23.
45. Subica AM, Guerrero E, Aitaoto N, Moss HB, Iwamoto D, Wu LT. Hazardous drinking, alcohol use disorders, and need for treatment among Pacific Islander young adults. Am J Orthopsychiatry 2020;90:557-66.
46. Floyd A, Sakellariou D. Healthcare access for refugee women with limited literacy: layers of disadvantage. Int J Equity Health 2017;16:195.
47. Morisako AK, Tauali'i M, Ambrose AJH, Withy K. Beyond the ability to pay: the health status of Native Hawaiians and Other Pacific Islanders in relationship to health insurance. Hawaii J Med Public Health 2017;76 (3 Suppl 1):36-41.
